Embodiments relate to a photoacoustic system for monitoring a laser ablation procedure in a target tissue, such as monitoring catheter tip position and temperature.
Chronic venous insufficiency (CVI) is caused by the reflux in one-way valves of the lower extremity venous system. CVI causes edema, discoloration, dermatitis, and ulceration in the affected limbs. Endovascular ablation of the superficial veins is a safe, minimally invasive, and efficacious treatment for moderate to severe CVI of the superficial veins of the lower extremity. This procedure has a success rate of 90-95%.
Endovenous laser therapy (EVLT) or endovenous laser ablation (EVLA) is a minimally-invasive method that is used to ablate superficial varicose veins. After accessing the desired vein, a thin fiber is inserted through a sheath into the diseased vein. Laser light is emitted through the fiber, and as the fiber is pulled back through the vein it delivers light energy to the surrounding tissue. The targeted tissue reacts with the light energy, generating heat and causing the vein to seal shut. Complications may occur from this therapy in the form of heat-induced thrombosis extending into the deep veins. There is also concern for recanalization of treated veins.
Current methods of ultrasound-guided endovenous ablation using laser-based fibers often lack precision in identifying the true location of the ablation fiber tip. Additionally, existing systems lack the ability to non-invasively determine the tissue temperature at the activated fiber tip in real time.
In one or more embodiments, a system for monitoring an ablation procedure in a target tissue includes a first light source for delivering light to the target tissue to generate photoacoustic signals and a second light source for delivering light to the target tissue for ablation therapy. The system further includes a beam mixer for receiving light from the first and second light sources to create a combined light beam. An ablation catheter including a single optical fiber receives the combined light beam from the beam mixer, wherein the combined light beam is emitted from a tip of the ablation catheter to perform simultaneous ablation therapy and photoacoustic monitoring of the ablation procedure in the target tissue in real time.
In one or more embodiments, a system for monitoring an ablation procedure in a target tissue includes a pulsed laser for delivering light pulses to the target tissue to generate photoacoustic signals and a continuous wave laser for delivering continuous wave light energy to the target tissue for ablation therapy. The system further includes a beam mixer for receiving light from the pulsed laser and the continuous wave laser to create a combined light beam. An ablation catheter including a single optical fiber receives the combined light beam from the beam mixer, wherein the combined light beam is emitted from a tip of the ablation catheter to simultaneously perform ablation therapy and to generate photoacoustic signals in the target tissue. The system further includes an ultrasound transducer for detecting the generated photoacoustic signals, and a processor in communication with the ultrasound transducer for processing the photoacoustic signals to create photoacoustic images of the tip of the ablation catheter to allow tracking of the tip in real time simultaneous to ablation therapy.
In one or more embodiments, a system for monitoring an ablation procedure in a target tissue includes a pulsed laser for delivering light pulses to the target tissue to generate photoacoustic signals and a continuous wave laser for delivering continuous wave light energy to the target tissue for ablation therapy. The system further includes a beam mixer for receiving light from the pulsed laser and the continuous wave laser to create a combined light beam. An ablation catheter including a single optical fiber receives the combined light beam from the beam mixer, wherein the combined light beam is emitted from a tip of the ablation catheter to simultaneously perform ablation therapy and to generate photoacoustic signals in the target tissue. The system further includes an ultrasound transducer for detecting the generated photoacoustic signals, and a processor in communication with the ultrasound transducer for processing the photoacoustic signals to monitor a temperature at the tip of the ablation catheter in real time simultaneous to ablation therapy.
As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms. The figures are not necessarily to scale; some features may be exaggerated or minimized to show details of particular components. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present invention.
Photoacoustic imaging is an imaging technology that allows for the ultrasonic detection of objects upon radiation of electromagnetic (EM) waves as an excitation. Using light as an excitation source, photoacoustic imaging uses a short, low-power, laser pulse to excite the target tissue. Consequent to rapid but small thermal expansion of the excited tissue, acoustic waves will be generated which convey information about optical properties of the tissue. In addition, these waves only arise from the optically excited region. Photoacoustic signals are also known to convey information about the temperature of the surrounding tissue.
The system disclosed herein uses photoacoustic imaging for monitoring a laser ablation procedure, such that accurate positioning of the ablation fiber (catheter) tip location as well as thermal regulation of delivered energy may be determined more precisely. Simultaneous to laser ablation therapy, the disclosed system provides real-time, accurate fiber tip tracking as well as monitoring of the temperature at the tip of the fiber and thermal dose deposition inside the ablated vein or other tissue. The disclosed system provides images of the tip of a laser ablation catheter, free of known ultrasound artifacts/noise (such as angular dependency and comet tail), and accurate and localized temperature information without the need for light delivery that is external or separate from the ablation catheter for photoacoustic imaging. Specifically, the system uses the same optical fiber to simultaneously carry both high-power continuous wave (CW) laser energy for ablation and low-power laser pulses for generating a photoacoustic signal at the tip of the catheter. The two laser outputs are combined for delivery into a single fiber, such as by using an optical component as described below.
In one embodiment, the beam mixer 16 may be a dichroic mirror or block which has different reflection or transmission properties of light at two different wavelengths. In other embodiments, the beam mixer 16 could include a cold mirror reflecting visible light wavelengths while transmitting infrared light wavelengths or could include a hot mirror reflecting infrared light wavelengths while transmitting visible light wavelengths. The beam mixer 16 can be positioned within the system 10 at an incidence angle, typically between 0 and 45 degrees, appropriate to receive, transmit, and reflect light from the lasers 12, 14 as desired. A focal lens 20 may also be positioned within the system 10 to focus light from the beam mixer 16 to the fiber 18.
In the ablation catheter 18, laser light is only emitted from a tip 22 portion of the catheter 18 (
With reference to
System 10 also provides the capability for accurate and localized temperature measurement without the need for using laser energy or any other device that is external to the body or separate from the ablation catheter 18. Temperature monitoring requires calibration, where the calibration process includes testing the system in human blood and determining a relationship (e.g. “lookup table”) between the photoacoustic signal and the temperature, as the strength (amplitude) of the generated photoacoustic signal at the catheter tip 22 will depend on the surrounding temperature. The photoacoustic signal also depends on several other parameters, including light fluence, absorption coefficient of the tissue, and the speed of sound. In contrast to methods which use external illumination for photoacoustic imaging, the light source (from pulsed laser 12) is internal to the disclosed system 10. Therefore, the thermal measurements of system 10 will be independent of fluence and the optical properties of the surrounding tissue since the catheter 18 is either in blood or certain unchanged tissue. In addition, temperature measurements will be highly localized at the catheter tip 22 for temperature/heat deposition monitoring and will not be affected by the tissue path. As such, the disclosed system 10 improves regulation of thermal energy delivery at the activated fiber tip 22 to ensure adequate ablation at all points of the treated vessel or other target tissue. In addition to temperature monitoring, the photoacoustic signals can be used to indicate the thermal damage to the selected vessels or other target tissue (i.e. indicating whether the vessel is thermally ablated or not). This is based on the changes of optical properties of ablated tissue versus non-ablated tissue.
A prototype system was developed, and ultrasound and photoacoustic experiments were conducted in realistic tissue-mimicking phantoms in which one straight vessel and one vessel going out of the imaging plane was made in the material.
Experimental results for the straight and angled fiber configurations of
In another experiment, a lower power pulsed laser was tested in human blood. The experimental setup is schematically illustrated in
Similar to the tissue-mimicking phantom experiments, fiber tip tracking experiments were also conducted in porcine tissue samples.
Lastly, the feasibility of using photoacoustic imaging according to the disclosed system to monitor a temperature increase in tissue was tested in a tissue-mimicking phantom.
There is no existing technology to help accurately locate the tip of the laser ablation catheter within vessels, especially in cases where ultrasound imaging has difficulties visualizing the fiber. Photoacoustic imaging offers significant advantages in visualizing the fiber tip, such as not being affected by the angular dependency in ultrasound and also being completely independent from ultrasound appearance of the tissue. As such, the photoacoustic image of the fiber tip is a background-free image that indicates the location of the tip only. By using photoacoustic imaging simultaneous with laser ablation therapy in a single fiber as in the disclosed system, the fiber tip can be accurately tracked and thermal dose deposition at the tip accurately measured. These advantages can significantly improve clinical endogenous laser ablation procedures at a low cost without requiring a change to existing clinical procedures.
In one example, using photoacoustic imaging to locate the tip of the fiber will simplify catheter tip location at the saphenofemoral junction. This may decrease the incidence of heat-induced thrombosis as well as the time needed to perform the procedure. Measuring the temperature at the catheter tip will help the physician to deliver the desired amount of thermal energy to the target tissue. This thermal energy may be adjusted to accommodate different target vessels as desired.
The photoacoustic system disclosed herein can also be used in a number of applications including, but not limited to, fiber tip detection in breast-conserving surgery (lumpectomy), guided-biopsy procedures, catheter-based photothermal treatment, catheter-based atrial fibrillation ablation, and other applications in which visualization and/or monitoring temperature of an external catheter, fiber, or the like is required.
While exemplary embodiments are described above, it is not intended that these embodiments describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention. Additionally, the features of various implementing embodiments may be combined to form further embodiments of the invention.
This application claims the benefit of U.S. provisional application Ser. No. 62/625,121 filed Feb. 1, 2018, the disclosure of which is hereby incorporated in its entirety by reference herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/016269 | 2/1/2019 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62625121 | Feb 2018 | US |